or Try an Advanced Search...

    Technical Analysis for TNXP - Tonix Pharmaceuticals Holding Corp.

    Grade Last Price % Change Price Change
    F 0.73 4.96% 0.03
    TNXP closed up 4.96 percent on Monday, July 1, 2024, on 10.26 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Very Strong Down Down Down
    Historical TNXP trend table...
    Date Alert Name Type % Chg
    MACD Bullish Signal Line Cross Bullish 0.00%
    Pocket Pivot Bullish Swing Setup 0.00%
    Volume Surge Other 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    NR7 Range Contraction 4.96%
    Narrow Range Bar Range Contraction 4.96%
    Wide Bands Range Expansion 4.96%
    Oversold Stochastic Weakness 4.96%
    Older End-of-Day Signals for TNXP ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 4 hours ago
    Possible Pocket Pivot about 6 hours ago
    60 Minute Opening Range Breakdown about 8 hours ago
    Down 3% about 8 hours ago
    Up 5% about 9 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    TNXP Chart by TradingView
    Basic chart:

    Profile

    Tonix Pharmaceuticals Holding Corp., a development stage specialty pharmaceutical company, focuses on the development of pharmaceutical products for the disorders of central nervous system. The company's lead product candidate includes TNX-102 SL, a dose and formulation of cyclobenzaprine for the treatment of fibromyalgia and post-traumatic stress disorder. It also has a pipeline of various other product candidates, including TNX-201, which is a treatment for certain types of headaches; and TNX-301. The company was founded in 2007 and is headquartered in New York, New York.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Health Sciences Drugs Pharmaceutical Products Disorders Post Traumatic Stress Disorder Headache Stage Specialty Pharmaceutical Fibromyalgia Seth Lederman

    Is TNXP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jul 1 Tonix Pharmaceuticals secures $34M DoD contract for antiviral program
    Jul 1 Tonix Pharmaceuticals Awarded Up to $34 Million U.S. Department of Defense Contract for Accelerated Development of Broad-Spectrum Antiviral Program
    Jun 27 Top Midday Decliners
    Jun 27 Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering
    Jun 27 Nike, Micron And 3 Stocks To Watch Heading Into Thursday
    Jun 26 Tonix Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
    Jun 25 Tonix Pharmaceuticals Presents Vaccine Platform Data in Keynote Talk at the Vaccine Congress 2024
    Jun 24 Peering Into Tonix Pharmaceuticals's Recent Short Interest
    Jun 21 7 F-Rated Penny Stocks to Avoid This June
    Jun 20 Tonix Pharmaceuticals Announces Positive Pre-NDA CMC Meeting with FDA for Tonmya™ for the Management of Fibromyalgia
    See more TNXP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 60.16
    52 Week Low 0.595
    Average Volume 965,417
    200-Day Moving Average 11.32
    50-Day Moving Average 4.18
    20-Day Moving Average 2.01
    10-Day Moving Average 1.07
    Average True Range 0.34
    RSI (14) 14.53
    ADX 64.09
    +DI 8.10
    -DI 62.59
    Chandelier Exit (Long, 3 ATRs) 4.57
    Chandelier Exit (Short, 3 ATRs) 1.61
    Upper Bollinger Bands 4.92
    Lower Bollinger Band -0.91
    Percent B (%b) 0.28
    BandWidth 290.66
    MACD Line -1.11
    MACD Signal Line -1.13
    MACD Histogram 0.0152
    Fundamentals Value
    Market Cap 42.91 Million
    Num Shares 58.6 Million
    EPS -9.26
    Price-to-Earnings (P/E) Ratio -0.08
    Price-to-Sales 4.85
    Price-to-Book 0.16
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.85
    Resistance 3 (R3) 0.84 0.80 0.83
    Resistance 2 (R2) 0.80 0.77 0.80 0.82
    Resistance 1 (R1) 0.76 0.75 0.78 0.77 0.82
    Pivot Point 0.72 0.72 0.73 0.72 0.72
    Support 1 (S1) 0.69 0.69 0.70 0.69 0.65
    Support 2 (S2) 0.64 0.67 0.64 0.64
    Support 3 (S3) 0.61 0.64 0.63
    Support 4 (S4) 0.61